Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 11, No 6 (2015) The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, N. V. Romanova, Yu. F. Osmolovskaya, S. P. Golitsyn
"... Chronic heart failure (CHF) and atrial fibrillation (AF) can rightly be called the epidemic ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... inhibitor intolerance and justify inclusion of this drug into reimbursement lists that allow to reduce risk ..."
 
Vol 15, No 6 (2019) Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs Abstract  similar documents
D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova
"... they could become the first-line drugs in patients with CHF or the risk of its development. ..."
 
Vol 16, No 5 (2020) Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes Abstract  similar documents
A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina
"... Aim. To conduct a comparative analysis of clinical and anamnestic characteristics, risk factors ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... Aim. To evaluate an influence of carvedilol on risk of hypoglycemia in patients with diabetes type ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... %) in patients with hypertension, IHD, CHF and AF, insufficient estimation of cardiovascular risk factors ..."
 
Vol 15, No 2 (2019) Current Predictors of Atrial Fibrillation Progression Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova
"... with hypertension (HT), coronary heart disease (CHD) and chronic heart failure (CHF) with recurrent AF. Material ..."
 
Vol 3, No 1 (2007) RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY Abstract  similar documents
M. L. Maximov
"... positively influences on cardiac hemodynamics and CHF symptoms, significantly reduces mortality risk ..."
 
Vol 10, No 4 (2014) DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... Aim. To study the structure of risk factors and associated cardiovascular and concomitant non ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... and cardiovascular death risks: OR=0.38, р=0.01 and OR=0.25, р=0.02, respectively. Other drugs revealed ..."
 
Vol 14, No 5 (2018) Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis Abstract  similar documents
D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova
"... , the risk of CHF and CHF-associated mortality in RA patients is 1.5-2.5 times higher than in the general ..."
 
Vol 8, No 4 (2012) ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? Abstract  similar documents
I. V. Zhirov
 
Vol 16, No 1 (2020) Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy Abstract  PDF (Eng)  similar documents
I. G. Kirillova, D. S. Novikova, T. V. Popkova, H. V. Udachkina, E. I. Markelova, Yu. N. Gorbunova, Yu. O. Korsakova, S. N. Gluchova
"... disease modifying anti-rheumatic drugs and glucocorticoids. CHF was verified in accordance with actual ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
 
Vol 4, No 1 (2008) ACHIEVEMENT OF LIPID TARGET PLASMA LEVELS IN PATIENTS OF HIGH CARDIOVASCULAR RISK: IS MEDICINE CHOICE IMPORTANT? Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... Guidelines are discussed. Problem of statin choice and problem of equivalence of generic drugs to original ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.001), mortality (р=0 ..."
 
Vol 6, No 1 (2010) COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, A. A. Serazhim, V. P. Voronina, M. A. Maksimova, L. Yu. Drozdova, A. V. Zakharova
"... ramipril Hartil and the original drug Tritace was demonstrated. Monotherapy efficacy was low in high-risk ..."
 
Vol 6, No 4 (2010) ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM? Abstract  similar documents
D. V. Nebieridze, A. S. Safarian
 
Vol 16, No 3 (2020) Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta Abstract  similar documents
R. N. Shepel, O. M. Drapkina
"... , stratifying risk and predicting CHF. However, it is unclear whether all of these biological markers ..."
 
Vol 13, No 2 (2017) FALLING OF SENILE AGE PATIENT AS AN ADVERSE EVENT ASSOCIATED WITH THE USE OF MEDICINES: CASE REPORT Abstract  similar documents
E. S. Ilina, O. T. Bogova, S. V. Gorbatenkova, D. A. Sychev
"... . In this clinical case, the development of serious adverse reaction is significantly associated with adverse drug ..."
 
Vol 9, No 5 (2013) PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
O. A. Shtegman
"... . The evaluation of drug therapy and patient awareness of the principles of non-drug CHF treatment were performed ..."
 
Vol 5, No 3 (2009) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. N. Tereshchenko, N. A. Dzhaiani
"... features of these drugs in CHF. The special attention is given to enalapril, that has the biggest evidence ..."
 
Vol 4, No 1 (2008) WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL Abstract  similar documents
M. N. Mamedov, M. B. Stroeva
"... Primary prevention of diabetes in persons with high cardiovascular risk is an actual problem ..."
 
Vol 4, No 5 (2008) COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... drug of simvastatin, Zocor, in patients with hyperlipidaemia in short-term study. Material and methods ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... and mortality in combined therapy of patients with CHF , because each additional drug may change in compliance ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... Aim. To identify risk factors of decompensation of chronic heart failure (CHF) and related ..."
 
Vol 12, No 6 (2016) HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT Abstract  similar documents
B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova
"... that almost all first-line drugs recommended for CHF treatment are effective in patients with DM. ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... be improved due to education activity directed to doctors and increase in clopidogrel drugs affordability. ..."
 
Vol 6, No 4 (2010) EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK Abstract  similar documents
N. V. Perova, E. I. Sokolov, G. N. Shchukina, V. A. Metelskaya
"... drug which has pleiotropic effects involving into the atherosclerosis progression. ..."
 
Vol 3, No 1 (2007) EFFECTS OF METABOLIC DRUG ELTACINE ON CLINICAL, FUNCTIONAL AND BIOCHEMICAL INDICES IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
R. M. Zaslavskaya, G. V. Lilitsa, Ye. V. Kalinina, I. A. Komissarova, L. N. Maximova
"... Aim. To study clinical efficacy of a new domestic metabolic drug Eltacine in patients with chronic ..."
 
Vol 14, No 6 (2018) Antihypertensive Efficacy of Fixed Combination of Amlodipine and Ramipril in Patients with Arterial Hypertension and Very High Cardiovascular Risk Abstract  PDF (Eng)  similar documents
O. Yu. Korennova, S. P. Podolnaya, E. P. Prihodko, E. A. Turusheva, S. N. Starinskaya, I. A. Вratishko, I. V. Druk
"... of amlodipine and ramipril in hypertensive patients with very high cardiovascular risk. Material and methods ..."
 
Vol 7, No 2 (2011) SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... The main issues of sudden cardiac death (SCD) epidemiology and risk stratification were considered ..."
 
Vol 5, No 1 (2009) SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, V. V. Yakusevich, A. D. Deev, A. A. Serazhim, T. V. Bobkova, L. P. Volkonskaya, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, J. V. Lukina, M. A. Maksimova, A. A. Serazhim, S. N. Tolpygina, E. V. Shilova
"... Aim. To evaluate possibility of complex pharmaceutical effect simultaneously on 2 risk factors ..."
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... Smoking is a well – known risk factor of many diseases. It influences the efficacy and safety ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... Aim. To evaluate the frequency of the prescription of cardiovascular drugs in patients before ..."
 
Vol 7, No 3 (2011) VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY Abstract  similar documents
E. P. Trukhacheva, M. V. Ezhov
"... . These drugs therapy associates with 30% risk reduction in mortality and coronary events. However , the threat ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... ) and/or coronary heart disease (CHD) as well as to study risk factors of erectile dysfunction. Material ..."
 
Vol 14, No 6 (2018) Angiotensin Converting Enzyme Inhibitors and the Risk of Lung Cancer – New Scientific Evidences or Another Example of “Pseudo-Evidence” Medicine? Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich
"... of the potential risk from taking these drugs is possible only if it is related to the proven positive effect ..."
 
Vol 4, No 5 (2008) EVALUATION OF QUALITY OF ARTERIAL HYPERTENSION CONTROL IN POPULATION OF VOLOGDA REGION Abstract  similar documents
A. I. Popugaev, G. Т Banshikov, A. A. Kolinko, N. A. Korolenko, R. A. Kasimov, Д. А. Rybakov, А. М. Kalinina
"... in villages take antihypertensive drugs more often, but they have more risk factors and associate conditions ..."
 
Vol 3, No 3 (2007) REDUCTION OF CUMULATIVE CARDIOVASCULAR RISK IN PATIENTS WITH ARTERIAL HYPERTENSION: THE ROLE OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS ACCORDING TO THE NEW EUROPEAN RECOMMENDATIONS Abstract  similar documents
M. N. Mamedov, N. A. Chepurina, Z. N. Tokareva, A. A. Evdokimova
"... Conception of total cardio-vascular risk plays important role in defining tactics of arterial ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..."
 
Vol 16, No 5 (2020) Actual Issues of the Cardiac Complications Risk Assessment and Correction in Non-Cardiac Surgery Abstract  similar documents
A. N. Sumin
"... for assessing cardiac risk of non-cardiac operations considering the emergence of new publications on this topic ..."
 
Vol 8, No 6 (2012) THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... pulse wave) with cardiovascular risk factors in women with rheumatoid arthritis (RA). Material ..."
 
Vol 15, No 2 (2019) Screening of People with High Blood Pressure in Moscow Region Abstract  similar documents
O. M. Drapkina, R. N. Shepel, E. S. Ivanova, E. S. Bulgakova, A. N. Kaburova, L. M. Zhamalov, Yu. D. Shalyagin, A. V. Kutcher, S. A. Vernadskiy
"... Region citizens about high blood pressure (BP) and draw their attention to this important risk factor ..."
 
Vol 16, No 5 (2020) Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko
"... Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... heart failure are analyzed. Different efficacy of the representatives of this class toward risks ..."
 
Vol 15, No 5 (2019) Comparative Analysis of Factors Affecting the Prognosis of Patients with Atrial Fibrillation According to the Results of the REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... predictors contributing to an increase in the risk of death: age over 75 years, permanent form of AF, CHF FC ..."
 
Vol 7, No 1 (2011) THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY Abstract  similar documents
V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
"... (Plavix) and its generic (Egitromb) in patients of high cardiovascular risk. Material and methods. Thirty ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... practice, adherence to drug therapy in patients with a combination of chronic heart failure (CHF ..."
 
Vol 14, No 5 (2018) The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness Abstract  similar documents
E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova
"... combinations (SPC) of antihypertensive drugs. Methods. At the first phase  of the study, according ..."
 
Vol 15, No 4 (2019) Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... ), worth special noticing in the classes of sartans and thiazide diuretics, since both drugs have a long ..."
 
Vol 16, No 6 (2020) Thiazide and Thiazide-like Diuretics in the Treatment of Arterial Hypertension: are there Any Differences? Abstract  similar documents
A. I. Kochetkov
"... of the first line antihypertensive drugs, which are equivalent in their effectiveness to other main ..."
 
Vol 11, No 1 (2015) THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER) Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich, N. P. Kutishenko, A. D. Deev, M. L. Ginzburg, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina
"... in-hospital mortality (p=0.014; χ2 Pearson) was detected in patients with RSPI=0; relative risk of in-hospital ..."
 
Vol 16, No 1 (2020) High Blood Pressure Variability is an Additional Cardiovascular Risk Factor Abstract  similar documents
A. V. Rodionov
"... measurement to poor adherence to therapy and abuse of short-acting antihypertensive drugs) affect the assessed ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... blockers play in achieving target figures of blood pressure and reducing cardiovascular risk is discussed ..."
 
Vol 13, No 6 (2017) ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY Abstract  similar documents
Yu. А. Bunin, S. V. Miklishanskaya
"... the possibilities of drug therapy in rate control strategy in CHF, depending on the size of the left ventricular ..."
 
Vol 7, No 5 (2011) EFFECT OF ERYTHROPOIETIN ON THE CLINICAL COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH ANEMIA: RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. M. Provotorov, S. A. Avdeeva
"... of anemia with erythropoietin and iron containing drugs additionally to the basic CHF/IHD therapy leads ..."
 
Vol 8, No 4 (2012) THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY Abstract  similar documents
M. Yu. Gilyarov
"... . Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered ..."
 
Vol 13, No 3 (2017) SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION Abstract  similar documents
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev
"... of the main modifiable risk factors could not be assessed fully due to the lack of information in patients ..."
 
Vol 9, No 2 (2013) LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK (LIS-2). DESIGN AND MEDICAL TREATMENT ESTIMATION Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. Yu. Martsevich, M. L. Ginzburg, N. P. Kutishenko, L. Yu. Drozdova, A. V. Akimova, A. Yu. Suvorov, M. M. Loukianov, N. A. Dmitrieva, O. V. Lerman, N. Yu. Zhuravskaya, E. V. Daniels, A. V. Fokina, V. N. Yudaev, V. P. Smirnov, A. M. Kalinina, S. V. Kotov, L. V. Stahovskaya
"... frequency of prescription of drugs with proven positive prognostic value in patients after stroke. ..."
 
Vol 12, No 4 (2016) Antiarrhythmic drugs use in elderly patients. Vaughan Williams class I and II drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... ), proarrhythmic effect (I A и I C) and high risk of drug interactions. Disopyramide use should be avoided due ..."
 
Vol 12, No 1 (2016) Interaction of rivaroxaban with amiodarone, verapamil and diltiazem in patients with atrial fibrillation: terra incognita Abstract  similar documents
S. N. Bel'diev
"... in plasma concentrations of rivaroxaban that is accompanied by increased risk of bleeding. According ..."
 
Vol 9, No 4 (2013) STATINS AND THE RISK OF DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina
"... the risk of diabetes mellitus (DM) in long-term therapy and use of high doses. Diabetogenic action ..."
 
Vol 6, No 4 (2010) EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE Abstract  similar documents
M. N. Mamedov, M. V. Stroeva, M. N. Kovrigina, E. A. Poddubskaya
"... in hypertensive men with high cardiovascular risk. Materials and methods. Hypertensive men (n=21) with high ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... . The difficulties of the antiplatelet treatment lie in balance between the necessary therapeutic effect and the risk ..."
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... of antiplatelet treatment lie in the balance between the necessary therapeutic effect of the drug and the risk ..."
 
Vol 8, No 6 (2012) TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE Abstract  similar documents
O. D. Ostroumova, G. N. Shchukina, V. M. Fomina
"... Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered ..."
 
Vol 16, No 6 (2020) What factors are Associated with the Development of Contras-induced Nephropathy in Elderly Patients with Acute Coronary Syndrome in Real Clinical Practice? Abstract  similar documents
M. Yu. Gilyarov, E. V. Konstantinova, P. V. Kovalets, A. V. Slivin, A. E. Udovichenko, A. P. Nesterov, O. N. Svetlova, A. V. Svet
"... .015). The risk of developing contrast-induced acute kidney injury was related the volume of contrast medium ..."
 
Vol 16, No 4 (2020) Epicardial Adipose Tissue as a New Target of Therapeutic Interventions Abstract  similar documents
M. A. Druzhilov, T. Y. Kuznetsova
"... and severity of supraventricular arrhythmias. There is also a lot of evidence of the influence of both non-drug ..."
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... as first-line drugs for stroke prevention, but in real medical practice antiplatelet drugs are often ..."
 
Vol 15, No 3 (2019) Hypertension and Headache: the Effect of Antihypertensive Drugs Abstract  similar documents
V. A. Parfenov, T. M. Ostroumova, O. D. Ostroumova
"... mechanisms. External risk factors, which can be associated with both migraine and HT, include the nature ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... Advanced age is the most important and independent risk factor for the development of atrial ..."
 
Vol 1, No 1 (2005) MENOPAUSE AND CARDIOVASCULAR RISK Abstract  similar documents
D. A. Anichkov, N. A. Shostak, A. D. Zhuravleva
"... A role of menopause as a cardiovascular risk factor is reviewed. Menopause influence ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... (AH) 1-2 stage with increased risk of cardiovascular events. Material and methods. The study ..."
 
Vol 16, No 1 (2020) The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion) Abstract  similar documents
M. V. Ezhov, A. Catapano, C. Escobar, V. V. Kukharchuk, M. I. Voevoda, O. M. Drapkina, S. A. Shalnova, A. V. Starodubova, V. S. Gurevich, I. I. Shaposhnik, O. O. Bolshakova, O. S. Oynotkinova, A. S. Alieva
"... LDL-C at low and moderate risk individuals without lipid-lowering drugs and as nutritive support ..."
 
Vol 11, No 1 (2015) CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, A. Yu. Suvorov, M. L. Ginzburg, A. D. Deev, S. A. Boytsov, A. V. Akimova, E. V. Daniels, N. A. Dmitrieva, L. Yu. Drozdova, N. Yu. Zhuravskaya, O. V. Lerman, Yu. V. Lukina, M. M. Loukianov, V. P. Smirnov, A. V. Fokina
"... was detected. Conclusion. Insufficient assignment of drugs with a proven effect on the prognosis in patients ..."
 
Vol 15, No 1 (2019) New Guidelines on Management of Arterial Hypertension: Key Similarities and Differences Abstract  similar documents
Zh. D. Kobalava, E. A. Troitskaya, E. L. Kolesnik
"... the importance of cardiovascular risk evaluation for treatment initiation and choice of optimal treatment ..."
 
Vol 16, No 2 (2020) Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry) Abstract  similar documents
E. Yu. Andreenkо, M. M. Loukianov, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, V. A. Dindikova, A. N. Makoveeva, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... Aim. To evaluate the gender characteristics, educational level, cardiovascular diseases (CVD) risk ..."
 
Vol 8, No 1 (2012) EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK Abstract  similar documents
I. M. Sokolov, N. A. Zheleznyakova
"... risk requires widespread use of combined therapy. Current approaches to selection of combination ..."
 
Vol 9, No 4 (2013) REAL PRACTICE OF STATINS USE AND ITS DEPENDENCE ON FOLLOW-UP IN THE SPECIALIZED MEDICAL CENTRE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (ACCORDING TO THE PROFILE REGISTER) Abstract  similar documents
S. Yu. Martsevich, O. V. Gaisenok, S. G. Tripkosh, Yu. V. Lukina, A. V. Zagrebel’nyy
"... Aim. To analyze tactics of statins use in patients with high cardiovascular risk on the base ..."
 
Vol 16, No 4 (2020) The Peculiarity of Process and Treatment of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus Abstract  similar documents
T. Yu. Demidova, O. A. Kislyak
"... levels risk of developing cardiovascular complications and chronic kidney disease. The combination ..."
 
Vol 6, No 5 (2010) FIXED LOW-DOSE COMBINATION OF LISINOPRIL AND HYDROCHLOROTHIAZIDE IN THE PREVENTION OF CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS Abstract  similar documents
A. O. Shevchenko, O. P. Shevchenko
"... to more effective blood pressure control, organoprotection improvement and side events risk reduction ..."
 
Vol 7, No 5 (2011) AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION Abstract  similar documents
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva
"... , amlodipine can be recommended as first-line drug for the treatment of HT associated with DM and IHD. ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... % of the population. Non-valvular AF increases the risk of ischemic stroke in 5-7 times. More than 50 ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... in a population of middle-aged men with different levels of total cardiovascular risk, and correlation between ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
 
Vol 14, No 4 (2018) Differences in the Incidence of Major Risk Factors in Patients with Ischemic or Hemorrhagic Stroke in the Siberian Population Abstract  similar documents
S. Yu. Nikulina, A. A. Chernova, D. A. Nikulin, V. A. Shulman, S. V. Prokopenko, I. M. Platunova, O. V. Marilovceva, I. I. Lebedeva, A. A. Semenchukov, D. A. Yakovleva, V. N. Maksimov, A. V. Kuskaeva
"... Background. The study of the incidence of risk factors (RF) of stroke for primary and secondary ..."
 
Vol 16, No 4 (2020) Felodipine in Treatment of Arterial Hypertension and Ischemic Heart Disease Abstract  similar documents
O. D. Ostroumova, I. A. Alautdinova, A. I. Kochetkov, S. N. Litvinova
"... are a heterogeneous group of drugs that have both general and individual pharmacokinetic and pharmacodynamic ..."
 
Vol 16, No 3 (2020) Economic Burden of Hypertension in the Russian Federation Abstract  similar documents
Yu. A. Balanova, A. V. Kontsevaya, A. O. Myrzamatova, D. K. Mukaneeva, M. B. Khudyakov, O. M. Drapkina
"... and methods. The calculation included the prevalence of hypertension in the RF and the relative risk ..."
 
Vol 12, No 5 (2016) Antiarrhythmic Drugs Use in Elderly Patients. Vaughan Williams Class III and IV Drugs Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, K. E. Zatolochina, A. P. Pereverzev, N. A. Chukhareva
"... . Аmioadarone is not considered as the drug of choice in elderly patients because of the high risk of serious ..."
 
Vol 15, No 6 (2019) Current Trends in the Treatment of Hypertension: Focus on Improving Prognosis. The Capabilities of an Amlodipine/Telmisartan Single-Pill Combination Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov
"... patients fixed-dose combinations of antihypertensive drugs as initial therapy. This concept is reflected ..."
 
Vol 8, No 4 (2012) COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»  similar documents
D. V. Nebieridze
 
Vol 15, No 5 (2019) Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them Abstract  similar documents
N. V. Pyrikova, O. N. Antropova, I. V. Osipova
"... , the prescription of this group of drugs requires consideration of the potential risks of complications, including ..."
 
Vol 15, No 5 (2019) Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) Abstract  similar documents
E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... Aim. To assess the demographic and clinical characteristics, drug treatment and outcomes ..."
 
Vol 14, No 6 (2018) Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study) Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
"... high cardiovascular risk in routine clinical practice, as well as the possible impact of educational ..."
 
Vol 10, No 3 (2014) NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS Abstract  similar documents
O. M. Drapkina, L. O. Palatkina
"... with the severity of chronic heart failure (CHF). Increasing number of patients with symptoms of CHF but without ..."
 
Vol 15, No 2 (2019) A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist Abstract  similar documents
S. R. Gilyarevskiy, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, I. I. Sinitsina
"... of antihypertensive drugs are reviewed in the article. The evidence that a flexible regimen of combination ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... body weight and is an important component of residual risk. HTG creates additional conditions ..."
 
Vol 7, No 4 (2011) GENDER DIFFERENCES IN THE EFFICACY OF RISK FACTORS CORRECTION AND TREATMENT COMPLIANCE IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. Y. Efanov, D. F. Nizamova, E. F. Dorodneva, I. V. Medvedev, S. V. Shalaev
"... of basic drugs taking were evaluated at baseline and after 6 months. The efficacy of risk factors ..."
 
Vol 10, No 4 (2014) FEATURES OF PIRIBEDIL USE IN THE TREATMENT OF MILD COGNITIVE IMPAIRMENTS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
N. S. Akimova, T. V. Martinovich, D. G. Persashvili, Y. G. Shvarts
"... in patients with chronic heart failure (CHF). Material and methods. Open randomized study of piribedil ..."
 
1 - 100 of 984 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)